Lung Cancer Clinical Trials

Showing 521-540 of 3,692 trials

Urolithin A in Patients With Previously Untreated Solid Tumors Receiving Immune Checkpoint Inhibitors

NCT07161310

The aim of this clinical study is to learn more about the effects of urolithin A (MitoPure®) on the immune system of cancer patients receiving immune checkpoint inhibitor-based therapies. Any effects will be compared with patients who take a placebo instead of urolithin A (MitoPure®).

Solid CancerNon-Small Cell Lung CancerMelanoma

Goethe University45 participantsStarted Jan 2026

Frankfurt, Germany

TERMINATEDPhase 2

Biomarkers of Response to Ipilimumab and Nivolumab in First-line NSCLC

NCT03425331

This research study is studying two immunotherapy drugs as a possible treatment for advanced non-small cell lung cancer (NSCLC). The drugs involved in this study are: * Ipilimumab * Nivolumab

Non-small Cell Lung Cancer

Dana-Farber Cancer Institute5 participantsStarted Apr 2018

Boston, Massachusetts, United States • Boston, Massachusetts, United States • Boston, Massachusetts, United States

RECRUITINGPhase 2/3

High Dose Dexamethasone to Reduce Postoperative Pain After Video-Assisted Thoracoscopic Surgery Lobectomy /Segmentectomy

NCT07213375

The aim is to conduct a randomized controlled trial (RCT) with a high dose arm (1mg/kg) vs a low dose (8mg in total) of steroid (Dexamethasone) given intravenous (IV) after the induction of anesthesia to "High-pain-responders" in patients undergoing VATS lobectomy/segmentectomy. The hypothesis is that a high dose of Dexamethasone can lower pain when coughing in the morning after VATS lobectomy/segmentectomy, in patients scoring as "High-pain-responders" on the Pain-Catastrophizing-Scale

AnalgeticLung Cancer (NSCLC)Video Assisted Thoracic Surgery (VATS)+1 more

Rigshospitalet, Denmark80 participantsStarted Sep 2025

Copenhagen, Copenhagen, Denmark

Urolithin A in Patients With Previously Untreated Solid Tumors Receiving Immune Checkpoint Inhibitors

Biomarkers of Response to Ipilimumab and Nivolumab in First-line NSCLC

High Dose Dexamethasone to Reduce Postoperative Pain After Video-Assisted Thoracoscopic Surgery Lobectomy /Segmentectomy

Related Searches

PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56

A Study Evaluating the Efficacy and Safety of ABP1011T Tablets in Patients With Advanced Solid Tumors

DAREONᵀᴹ-8: A Study to Test How Well Different Doses of BI 764532 in Addition to Standard of Care Are Tolerated by People With Advanced Small Cell Lung Cancer

A Study of Lutetium [177Lu]-BL-ARC001 in Patients With Locally Advanced or Metastatic Lung Cancer, Breast Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors

Study Comparing ZG006 With Investigator-Selected Chemotherapy in Participants With Relapsed Small Cell Lung Cancer

C-TIL051 in Non-Small Cell Lung Cancer

CXCR4 PET/CT for Predicting Outcome in Limited-Stage Small Cell Lung Cancer

Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer

Dynamics of 18-FDG Uptake in Stage III/IV Non Small Cell Lung Cancer During First Line Pembrolizumab Treatment

Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy

Adjuvant Treatment With Cisplatin-based Chemotherapy Plus Concomitant Atezolizumab in Patients With Stage I (Tumors ≥ 4cm), IIA, IIB, and Select Stage III [Any T1-3 N1-2 and T4N0-2] Resected Non-small Cell Lung Cancer (NSCLC) and the Clearance of Circulating Tumor DNA (ctDNA)

Robot-Assisted vs. Video-Assisted Lobectomy for NSCLC (RAVAR)

Lazertinib for NSCLC Harboring Activating EGFR Mutations in TKI naïve Patients

The HER Project: HRD in EGFR-mutated NSCLC

Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma

BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab

Real-World Study of Toripalimab in Extensive-Stage Small Cell Lung Cancer